GSP Crop Science Limited to Acquire Balance 21% Stake in GSP Intermediates Private Limited for Rs. 3,15,00,000

GSP Crop Science Limited announced on May 14, 2026, that its Board of Directors has approved the acquisition of the remaining 21% equity stake in GSP Intermediates Private Limited (GIPL), its subsidiary, for a total cash consideration of Rs. 3,15,00,000/-. The board meeting, which commenced at 7:00 P.M. and concluded at 7:22 P.M., also resolved that upon completion of the transaction, GIPL will be converted into a wholly-owned subsidiary of the company. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Acquisition Details

The transaction involves the purchase of 31,50,000 equity shares of Rs. 10/- each from Mr. Rakeshkumar V. Shah, an existing shareholder of GIPL. The acquisition is being carried out at par value through a cash consideration, with the price validated by a valuation report issued by a Registered Valuer. The key parameters of the deal are summarised below:

Parameter: Details Target Entity: GSP Intermediates Private Limited (GIPL) Shares Acquired: 31,50,000 equity shares of Rs. 10/- each Stake Acquired: 21% (remaining balance) Total Consideration: Rs. 3,15,00,000/- Consideration Type: Cash at par value (Rs. 10/- per share) Seller: Mr. Rakeshkumar V. Shah Post-Acquisition Status: GIPL to become a wholly-owned subsidiary Indicative Completion Timeline: Within approximately 4 months Regulatory Approvals Required: None (subject to applicable local laws)

The transaction qualifies as a Related Party Transaction, given that GIPL is already a subsidiary of GSP Crop Science Limited, and has been conducted at arm's length based on the registered valuer's report.

About GSP Intermediates Private Limited

GIPL was incorporated on August 18, 2022, and operates in the Agro-Chemicals sector, engaged in the manufacturing and processing of agrochemical intermediates and allied products. The company carries a paid-up capital of Rs. 1500.00 lakh. GIPL remained in a pre-operative phase during its initial years following incorporation and commenced commercial production in the later part of FY 2024-2025.

The turnover history of GIPL is as follows:

Financial Year: Turnover (Rs. In lakh) August 18, 2022–2023: - 2023-2024: - 2024-2025: 122.01

Strategic Rationale

GSP Crop Science Limited has outlined several strategic objectives behind converting GIPL into a wholly-owned subsidiary:

Enable seamless operational and manufacturing integration within the group

Provide complete strategic and financial control over GIPL

Support long-term manufacturing scalability and operational flexibility

Simplify the group structure and governance framework

Align future investments and expansion plans with the business objectives of GSP Crop Science Limited

The disclosure was signed by Kamleshbhai D Patel, Company Secretary & Compliance Officer (M. No. FCS 8018), on behalf of GSP Crop Science Limited. Further details are available on the company's website at www.gspcrop.in .

GSP Crop Science Limited has made the audio recording of its Q3FY26 earnings conference call available on the company website following the completion of the earnings discussion held on April 17, 2026. The company informed stock exchanges BSE and NSE about the recording availability through a regulatory filing under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Conference Call Completion and Recording Access

The earnings call was successfully conducted on Friday, April 17, 2026, where management discussed the company's financial performance for the third quarter and nine months ended December 31, 2025. The audio recording is now accessible through the company's website link provided in the regulatory filing.

Parameter: Details Call Date: Friday, April 17, 2026 Time: 3:30 PM IST Host: Equirus Securities Focus: Q3 & 9M FY26 performance Recording Access: Company website Filing Date: April 18, 2026

Financial Performance Highlights

The investor presentation revealed strong consolidated financial performance for the nine-month period, with significant growth across key metrics that were discussed during the conference call.

Consolidated Results (9M FY26)

Metric: 9M FY25 (₹ Million) 9M FY26 (₹ Million) Growth (%) Revenue: 9,794 11,146 +14% EBITDA: 1,168 1,538 +32% PAT: 596 751 +26% EBITDA Margin: 11.92% 13.80% +188 bps PAT Margin: 6.09% 6.74% +65 bps

Standalone Performance (9M FY26)

Metric: 9M FY25 (₹ Million) 9M FY26 (₹ Million) Growth (%) Revenue: 10,799 11,766 +9% EBITDA: 1,058 1,296 +23% PAT: 533 682 +28% EBITDA Margin: 9.79% 11.01% +122 bps PAT Margin: 4.93% 5.80% +87 bps

Business Performance Drivers

The revenue growth was primarily driven by increased business in the domestic B2C segment. Key product performance included new product sales of ₹366.00 million and growth in established brands including PCT-410 (₹80.00 million increase), Torch (₹107.00 million increase), Author (₹90.00 million increase), and Runout (₹47.00 million increase).

The company's international business showed strong momentum with 20% growth over the previous year, driven by planned sales in Brazil, USA, and Africa regions. New registrations in Brazil for Chlorpyrifos contributed to improved sales performance.

Regulatory Compliance

The audio recording availability was communicated to both BSE and NSE through proper regulatory channels. Company Secretary & Compliance Officer Kamleshbhai D Patel signed the regulatory filing on April 18, 2026, ensuring compliance with disclosure requirements for post-earnings call documentation.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.